Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alterations in thyroid function after cholecystographic contrast agents

A N Hunter, H Meinhold, J R Stockigt

    Australian and New Zealand Journal of Medicine
    |April 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.

    Internal medicine journal·2009
    Same author

    Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response.

    Internal medicine journal·2003
    Same author

    Free thyroid hormone measurement. A critical appraisal.

    Endocrinology and metabolism clinics of North America·2001
    Same author

    Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours.

    European journal of nuclear medicine·2000
    Same author

    Gene expression of receptors and enzymes involved in GABAergic and glutamatergic neurotransmission in the CNS of rats behaviourally dependent on ethanol.

    British journal of pharmacology·2000
    Same author

    Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain.

    Endocrinology·2000
    Same journal

    Gastroenterological Society of Australia, Annual Scientific Meeting, May 1980.

    Australian and New Zealand journal of medicine·2020
    Same journal

    'A touch of sugar'--a dangerous euphemism still alive and well.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Silent myocardial ischaemia following methysergide overdose.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Extensive jugular and upper limb thrombosis in a patient with factor V Leiden mutation and non-Hodgkin's lymphoma.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Visual loss as the presenting feature of giant cell arteritis.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Lymphoproliferative disease causing angioedema--an uncommon association.

    Australian and New Zealand journal of medicine·2001
    See all related articles

    Radiographic contrast agents can alter thyroid hormone levels, potentially leading to misdiagnosis of hyperthyroidism. Caution is advised when using these agents for thyroid conditions.

    Area of Science:

    • Endocrinology
    • Radiology

    Background:

    • Radiographic contrast agents are widely used for diagnostic imaging.
    • Oral cholecystographic agents have known interactions with thyroid hormone metabolism.

    Purpose of the Study:

    • To elucidate the diverse effects of radiographic contrast agents on thyroid hormones in humans.
    • To compare the impact of oral cholecystographic agents versus renally-excreted contrast agents on thyroid function.

    Main Methods:

    • Analysis of serum triiodothyronine (T3) and thyroxine (T4) levels in subjects exposed to contrast media.
    • Evaluation of the deiodination pathways of iodothyronines.
    • Comparison of effects between liver-uptake (cholecystographic) and renal-excretion (angiography/urography) contrast agents.

    Related Experiment Videos

    Main Results:

    • Oral contrast agents can decrease T3 and increase reverse T3 by inhibiting deiodination.
    • Acute increases in T4 may occur, mimicking hyperthyroidism.
    • Hyperthyroidism can be precipitated in susceptible individuals.
    • Renally-excreted agents have a less potent effect.

    Conclusions:

    • Contrast media can cause diagnostic dilemmas by altering thyroid hormone profiles.
    • Use of oral contrast agents in hyperthyroidism management requires caution due to potential worsening of the condition.
    • Concomitant use with antithyroid drugs is recommended for hyperthyroidism treatment.
    • Consider contrast media exposure in cases of unexpected hyperthyroidism exacerbation or T4/T3 discrepancies.